Finny logo
Finny logo
Cara Therapeutics, Inc. (CARA)
71
  • CONTENT
  • SOURCES
Jefferies Financial Group Weighs in on Cara Therapeutics Inc’s Q3 2020 Earnings (NASDAQ:CARA)
Cara Therapeutics Inc (NASDAQ:CARA) – Equities researchers at Jefferies Financial Group dropped their Q3 2020 earnings estimates for Cara Therapeutics in a research report issued to clients and investors on Tuesday, October 20th. Jefferies Financial Group analyst C. Howerton now forecasts that the biopharmaceutical company will post earnings of ($0.77) per share for the quarter, […]
Q3 2020 Earnings Estimate for Cara Therapeutics Inc (NASDAQ:CARA) Issued By Jefferies Financial Group
Cara Therapeutics Inc (NASDAQ:CARA) – Equities researchers at Jefferies Financial Group cut their Q3 2020 earnings per share estimates for shares of Cara Therapeutics in a report issued on Tuesday, October 20th. Jefferies Financial Group analyst C. Howerton now expects that the biopharmaceutical company will earn ($0.77) per share for the quarter, down from their […]
Cara Therapeutics (NASDAQ:CARA) Upgraded by BidaskClub to Hold
Cara Therapeutics (NASDAQ:CARA) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday, BidAskClub reports. Other equities analysts have also recently issued research reports about the stock. Canaccord Genuity reiterated a “buy” rating and issued a $30.00 target price on […]
Cara Therapeutics (NASDAQ:CARA) Rating Increased to Hold at BidaskClub
Cara Therapeutics (NASDAQ:CARA) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Wednesday, BidAskClub reports. A number of other brokerages have also recently commented on CARA. Canaccord Genuity reaffirmed a “buy” rating and set a $30.00 price target on shares of Cara Therapeutics in […]
Research Analysts’ Upgrades for October, 22nd (CARA, CENTA, CHGG, CTRA, DKILY, DRRX, ELS, EMKR, ENLC, ET)
Research Analysts’ upgrades for Thursday, October 22nd: Cara Therapeutics (NASDAQ:CARA) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $16.00 target price on the stock. According to Zacks, “Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new […]
Cara Therapeutics Inc (NASDAQ:CARA) Insider Joana Goncalves Sells 2,000 Shares
Cara Therapeutics Inc (NASDAQ:CARA) insider Joana Goncalves sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 20th. The stock was sold at an average price of $15.00, for a total transaction of $30,000.00. Following the completion of the transaction, the insider now owns 33,373 shares of the company’s stock, […]
Cara Therapeutics (NASDAQ:CARA) Stock Rating Upgraded by Zacks Investment Research
Cara Therapeutics (NASDAQ:CARA) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Thursday, Zacks.com reports. The firm presently has a $16.00 price objective on the biopharmaceutical company’s stock. Zacks Investment Research‘s target price suggests a potential upside of 11.97% from the company’s current price. […]
Cara Therapeutics Inc (NASDAQ:CARA) Sees Significant Growth in Short Interest
Cara Therapeutics Inc (NASDAQ:CARA) was the recipient of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 4,410,000 shares, an increase of 14.8% from the September 15th total of 3,840,000 shares. Approximately 10.3% of the shares of the stock are short sold. Based on […]
Cara Therapeutics (NASDAQ:CARA) Upgraded to “Hold” by BidaskClub
Cara Therapeutics (NASDAQ:CARA) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a report issued on Wednesday, BidAskClub reports. Several other brokerages have also recently commented on CARA. Zacks Investment Research cut shares of Cara Therapeutics from a “buy” rating to a “hold” rating in a research note on Friday, August […]
Cannabis Stock Gainers And Losers From October 20, 2020
GAINERS: KushCo Holdings (OTCQX: KSHB ) shares closed up 0.79% at $14.52 CURE Pharmaceutical Hldg (OTCQB: CURR ) shares closed up 1.19% at $12.26 Harvest Health (OTCQX: HRVSF ) shares closed up 1.62% at $1.62 Auxly Cannabis Group (OTCQX: CBWTF ) shares closed up 0.27% at $0.27 Cara Therapeutics (NASDAQ: CARA ) shares closed up 14.86% at $6.68 Curaleaf Holdings (OTCQX: CURLF ) shares closed up 5.47% at … Full story available on Benzinga.com
Cara Therapeutics (CARA) earnings: expect $5 million revenue
Cara Therapeutics (CARA) is announcing earnings on May 08, 2019. What should you expect?
Cara Therapeutics (CARA): a bullish outlook
Cara Therapeutics is considered highly speculative at this point, but it has demonstrated sufficient progress so investors with a high-risk appetite are keeping a close eye on it. What's CARA stock price forecast?
Cara Therapeutics (CARA): where does the stock go from here?
ValuEngine upgraded Cara Therapeutics (NASDAQ: CARA) today, and the stock shot up 11% in mid-day trading. What is the CARA stock price forecast?
Follow Us